Owner Eisai R & D Management Co., Ltd.

Inventors Suzuki, Yuichi; Sakai, Miyuki; Ueno, Koshi; Sasaki, Atsushi; Ito, Koichi; Ishihara, Hiroki; Kubota, Atsuhiko

Agent Davies Collison Cave

Pub. Number AU-B-2005240928

PCT Pub. Number WO2005/108389

Priority 2004-142437 12.05.04 JP

Filing date 11 May 2005

Wipo publication date 17 November 2005

Acceptance publication date 19 August 2010

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/454 (2006.01)

A61K 31/4725 (2006.01)

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/08 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or